NPI: 1952698417 · LAS VEGAS, NV 89103 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/06/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/06/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,153 | $300K |
| 2019 | 30,784 | $420K |
| 2020 | 34,758 | $408K |
| 2021 | 34,594 | $323K |
| 2022 | 27,301 | $234K |
| 2023 | 18,219 | $391K |
| 2024 | 6,397 | $365K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 63,444 | 2,547 | $2.44M |
| A4657 | Syringe, with or without needle, each | 6,074 | 1,969 | $2K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 51,076 | 1,597 | $729.07 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,195 | 322 | $209.16 |
| 85048 | 3,971 | 1,476 | $0.00 | |
| 83970 | 3,369 | 1,263 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,341 | 398 | $0.00 |
| 83540 | 2,483 | 931 | $0.00 | |
| 85041 | 4,088 | 1,516 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 11,937 | 1,569 | $0.00 |
| 82108 | 168 | 61 | $0.00 | |
| 85045 | 35 | 17 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 23,112 | 1,107 | $0.00 |
| 82728 | 2,434 | 928 | $0.00 | |
| 83550 | 1,824 | 763 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 283 | 86 | $0.00 |
| 90674 | 61 | 27 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 115 | 49 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 196 | 54 | $0.00 |